genetic engineering

Sherlock Biosciences Aims to Create Dx Tool for 'Where Testing Should be Done, But Isn't'
Premium

Two new grants are helping the company develop its SHERLOCK and INSPECTR technologies as the basis for creating innovative diagnostics.

Sherlock Biosciences Closes $31M Series A Financing Round

The company launched last month with initial financing of $35 million and licenses to CRISPR and synthetic biology technology from the Broad and Harvard.

genetic engineering

Sherlock Biosciences Aims to Create Dx Tool for 'Where Testing Should be Done, But Isn't'
Premium

Sherlock Biosciences Closes $31M Series A Financing Round

Congress Reintroduces SALSA, Taking up PAMA Reform Once Again

Lucira Health Combo Flu/COVID-19 MDx Test Gets Regulatory Approval in Australia

Burning Rock Q4 Revenues Down 4 Percent Due to COVID-19 Resurgence in China

Todos Medical Subsidiary Inks US Commercialization Deal for Acumen Diagnostics Sepsis PCR Test

InfanDx Restructures After Halting Development of Hypoxic-Ischemic Encephalopathy Test

FDA Grants Emergency Use Authorization for BioSynchronicity COVID Antigen Test

genetic engineering

Sherlock Biosciences Aims to Create Dx Tool for 'Where Testing Should be Done, But Isn't' Premium

Sherlock Biosciences Closes $31M Series A Financing Round

Congress Reintroduces SALSA, Taking up PAMA Reform Once Again

Lucira Health Combo Flu/COVID-19 MDx Test Gets Regulatory Approval in Australia

Burning Rock Q4 Revenues Down 4 Percent Due to COVID-19 Resurgence in China

Todos Medical Subsidiary Inks US Commercialization Deal for Acumen Diagnostics Sepsis PCR Test

InfanDx Restructures After Halting Development of Hypoxic-Ischemic Encephalopathy Test

FDA Grants Emergency Use Authorization for BioSynchronicity COVID Antigen Test

Sherlock Biosciences Aims to Create Dx Tool for 'Where Testing Should be Done, But Isn't'
Premium